Pharsight

1. Numbrino patents expiration

Drug Patent Number	Company	Drug Patent Title	Drug Patent Expiry
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US10231961	OMNIVIUM PHARMS	Pharmaceutical compositions and methods of using the same	Feb, 2037 (13 years from now)
US10973811	OMNIVIUM PHARMS	Pharmaceutical compositions and methods of using the same	Feb, 2037 (13 years from now)
US10894012	OMNIVIUM PHARMS	Pharmaceutical compositions and methods of using the same	Feb, 2037 (13 years from now)
US10857095	OMNIVIUM PHARMS	Pharmaceutical compositions and methods of using the same	Feb, 2037 (13 years from now)
US10420760	OMNIVIUM PHARMS	Pharmaceutical compositions and methods of using the same	Feb, 2037 (13 years from now)
US10413505	OMNIVIUM PHARMS	Pharmaceutical compositions and methods of using the same	Feb, 2037 (13 years from now)
US10149843	OMNIVIUM PHARMS	Pharmaceutical compositions and methods of using the same	Feb, 2037 (13 years from now)
US10016407	OMNIVIUM PHARMS	Pharmaceutical compositions and methods of using the same	Feb, 2037 (13 years from now)
US9867815	OMNIVIUM PHARMS	Pharmaceutical compositions and methods of using the same	Feb, 2037 (13 years from now)
US10933060	OMNIVIUM PHARMS	Pharmaceutical compositions and methods of using the same	Feb, 2037 (13 years from now)
US11040032	OMNIVIUM PHARMS	Pharmaceutical compositions and methods of using the same	Feb, 2037 (13 years from now)

Drug Exclusivity	Drug Exclusivity Expiration
New Product (NP)	Jan 10, 2023

Drugs and Companies using COCAINE HYDROCHLORIDE ingredient

Market Authorisation Date: 10 January, 2020

Treatment: A method for treating a subject with uveal melanoma with unresectable hepatic metastases; Method for the induction of local anesthesia of the mucous membranes; Method for the induction of local anesth...

Dosage: SOLUTION;NASAL